Meningococcal vaccine groups C Y W - Baxter International
Alternative Names: Mening CYW vaccineLatest Information Update: 24 Jul 2003
At a glance
- Originator Baxter International
- Class
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Meningococcal group C infections; Meningococcal group W-135 infections; Meningococcal group Y infections
Most Recent Events
- 24 Jul 2003 Discontinued - Preclinical for Meningococcal group C infections in USA (unspecified route)
- 24 Jul 2003 Discontinued - Preclinical for Meningococcal group W-135 infections in USA (unspecified route)
- 24 Jul 2003 Discontinued - Preclinical for Meningococcal group Y infections in USA (unspecified route)